Physician profile
Michael C Doarn
NPI 1104053966
$38,289.75
in general payments reported to CMS, 2019-2025
34 companies · $6,287 in 2025
The $6,287 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,320 · 2020: $359 · 2021: $2,148 · 2022: $2,653 · 2023: $20K · 2024: $5,574 · 2025: $6,287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $6,727 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,375 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,675 · Travel and Lodging: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,275.00 |
| Food and Beverage | $6,727.43 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,375.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,675.00 |
| Travel and Lodging | $757.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $27,091.49 | 2021-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Mvp Orthopedics INC | $2,583.84 | 2021-2023 | |
| Arthrex, INC. | $1,398.02 | 2019-2025 | |
| Coastal Medical Technologies LLC | $1,280.55 | 2023-2025 | |
| Polynovo North America LLC | $1,257.11 | 2024-2025 | Novosorb Btm |
| Stryker Corporation | $960.62 | 2020-2023 | Variax |
| Integra Lifesciences Corporation | $390.47 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Endo Pharmaceuticals INC. | $317.62 | 2021-2023 | Xiaflex |
| Trimed, INC. | $280.75 | 2023 | |
| Skeletal Dynamics INC | $241.91 | 2023 | Implate, Align, Ijs |
| Orthofix Medical, INC. | $238.82 | 2022-2023 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $197.24 | 2024 | Dvr Anatomic Kickstand, A.L.P.S. |
| Smith+Nephew, INC. | $178.14 | 2022-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Encore Medical, Lp | $177.75 | 2020 | |
| Sonex Health, INC. | $170.38 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocircuit Technologies INC | $153.70 | 2025 | Nerve Tape |
| Linvatec Corporation | $150.33 | 2024 | Biobrace 23mm |
| Acumed LLC | $147.51 | 2025 | Acumed, Inframe Implant |
| Depuy Synthes Sales INC. | $121.13 | 2023 | Va-Lcp |
| Exsomed Corporation | $96.85 | 2022 | |
| Endo USA, INC. | $93.19 | 2024-2025 | Xiaflex |
| Checkpoint Surgical, INC | $87.97 | 2021 | |
| Anika Therapeutics, INC. | $84.90 | 2023-2024 | Wristmotion, Total Anika, Integrity |
| Trice Medical, INC. | $81.41 | 2022 | |
| Avita Medical Americas, LLC | $72.72 | 2024 | |
| Horizon Therapeutics Plc | $72.52 | 2022-2023 | Krystexxa |
| Acera Surgical, INC. | $55.21 | 2023-2024 | Restrata Wound Matrix |
| Conetic Solutions, INC. | $52.54 | 2019 | |
| Illuminoss Medical, INC. | $51.36 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $51.11 | 2019 | |
| Osiris Therapeutics INC. | $48.17 | 2019 | |
| Bioventus LLC | $46.57 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Ethicon US, LLC | $36.61 | 2023 | Stratafix |
| Kerecis Limited | $21.24 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Doarn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.